Opioid Dose Falls When Pain Is Treated, Not Tapered

An opioid dose falls one of two ways. Either a taper is imposed on the patient, or the need drops because the pain generator was treated. Treating the pain input lets the dose come down. It also reverses the tolerance and hyperalgesia behind it. Why the dose comes down predicts whether the drop holds.

Request an Appointment Call (314) 463-0100

In addiction medicine, a falling opioid dose is usually read one way: somebody tapered the patient. The dose is something done to a person. The clinical question is how fast and how well it was done.

There is a second route to the same number, and it ends with a different patient. The need itself falls, because the source of the pain was treated. Hold onto that difference. On a prescription record, the two look the same. To the person living through them, they feel nothing alike.

Is it dangerous to taper opioids?

The harms of a bad taper are well measured. One cohort followed 113,618 patients on stable higher-dose opioid therapy. Tapering was tied to 9.3 overdose events per 100 person-years, against 5.5 in periods without a taper. Mental health crises ran 7.6 against 3.3. The faster the dose came down, the worse both got. A follow-up analysis found the higher risk lasting up to two years after the taper began. We covered that work when it came out: opioid tapering and the risk of overdose or mental health crisis.

So a lower dose is not automatically a good result. A taper is a treatment with its own risks. Whether it helps depends almost entirely on what else changed.

How can an opioid dose come down without a forced taper?

Long-term opioid use can cause two separate problems. Both look like pain that is not treated enough. Tolerance means the drug still works, but you need more of it. Opioid-induced hyperalgesia means the nervous system has been reset toward pain. More drug then feeds the problem instead of fixing it. The proposed causes include the central glutamate system and NMDA receptor activation. Another is spinal dynorphin. A third is descending facilitation, where signals from the brain turn pain up.

The clinical tell is what a higher dose actually buys. With tolerance, it helps, at least for a while. With hyperalgesia, it buys a short gain and then a worse baseline. Pain often spreads beyond where it started. One review puts it bluntly: where hyperalgesia is at work, more opioid prescribing is largely futile.

This is where the second route comes in. A 2019 review of opioid tolerance and hyperalgesia makes the point. Interventional treatments that cut the pain input can let the opioid dose come down. In doing so, they can undo the processes that caused tolerance and hyperalgesia in the first place. The dose falls because something was treated. It is not a target imposed on the patient.

How many patients get off opioids when the pain is treated?

On International Overdose Awareness Day in August 2026, Dr. Gurpreet Singh Padda, MD, MBA, MHP published the opioid figures from his interventional pain practice. He did not issue a position statement.

New patients arrive on an average of more than 90 morphine milligram equivalents per day. They have been in pain for more than two and a half years.
Within 90 days of active interventional treatment, 21% are fully off opioid pain medicine.
Within one year, 34% are fully off all opioid pain medicine.
Of those who cannot be fully weaned, the large majority are brought below 30 MME per day.

Those are figures the practice reported for that group, not trial outcomes, and individual results vary. The release ran on AP News; the full announcement is here.

Where this matters for addiction treatment

About one in twenty patients in that practice is treated for addiction and severe pain at the same time. These patients tend to fall between two services. Pain clinics are wary of the addiction history. Addiction programs are not set up to treat the pain. Both problems are real at once. Treating only one of them reliably makes the other worse.

The lesson is not that everyone should be weaned. It is that why a dose comes down predicts whether the drop holds. A taper against a pain generator nobody has treated is just arithmetic. The cohort data above show what tends to happen next. A drop that follows treatment of the pain generator is a different event.

It is also worth being honest about the limits of the evidence. A systematic review looked at opioid-induced hyperalgesia outside of surgery. It found the signal real in lab models. But the results were too mixed to measure its clinical impact. Hyperalgesia is something to suspect and test for. It is not a diagnosis to assume.

What should you ask if your opioid dose keeps climbing?

Maybe you, or someone you treat, are on a dose that keeps climbing with no gain in function. The question is not only how to come down. It is what has been done to find and treat the pain generator. See our approach to opioid addiction treatment, and read about Dr. Padda.

Frequently asked questions

What is an effective strategy for tapering opioids?

Treat what is causing the pain, not only the dose. When interventional treatments cut the pain input, the need itself falls. The dose can then come down as a result. That can also reverse the tolerance and hyperalgesia behind it. A taper against a pain generator nobody has treated is just arithmetic. Why the dose comes down predicts whether the drop holds.

Is tapering opioids too fast dangerous?

Yes. One cohort followed 113,618 patients on stable higher-dose opioid therapy. Tapering was tied to more overdose events and more mental health crises. The faster the dose came down, the worse both got. A follow-up analysis found the higher risk lasting up to two years after the taper began. A dose cut is a treatment with its own risks.

What is the difference between opioid tolerance and hyperalgesia?

With tolerance, the drug still works but you need more, and a higher dose helps for a while. With opioid-induced hyperalgesia, the nervous system has been reset toward pain. More drug feeds the problem. A higher dose buys a short gain and then a worse baseline. Pain often spreads beyond where it started.

Sources

Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411–419. PMID 34342618 · DOI 10.1001/jama.2021.11013.
Fenton JJ, Magnan E, Tseregounis IE, Xing G, Agnoli AL, Tancredi DJ. Long-term risk of overdose or mental health crisis after opioid dose tapering. JAMA Network Open. 2022;5(6):e2216726. PMID 35696163 · DOI 10.1001/jamanetworkopen.2022.16726.
Mercadante S, Arcuri E, Santoni A. Opioid-induced tolerance and hyperalgesia. CNS Drugs. 2019;33(10):943–955. PMID 31578704 · DOI 10.1007/s40263-019-00660-0.
Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia — when is enough too much? A review of opioid-induced tolerance and hyperalgesia. The Lancet. 2019;393(10180):1558–1568. PMID 30983591 · DOI 10.1016/S0140-6736(19)30430-1.
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145–161. PMID 21412369.
Yang DZ, Sin B, Beckhusen J, Xia D, Khaimova R, Iliev I. Opioid-induced hyperalgesia in the nonsurgical setting: a systematic review. American Journal of Therapeutics. 2019;26(3):e397–e405. PMID 29726847 · DOI 10.1097/MJT.0000000000000734.

Bibliographic records in this article were retrieved from PubMed. Every reference links to its PubMed record and DOI.